Related Experiment Video
Updated: Dec 24, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Drug interactions between statins and antiretroviral agents
David Burger1, Erik Stroes, Peter Reiss
1Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, 6525 GA Nijmegen, The Netherlands. D.Burger@akf.umcn.nl
Combining statins and antiretroviral agents can cause significant drug-drug interactions. This can lead to decreased effectiveness of statins or an increased risk of serious side effects like rhabdomyolysis.
Area of Science:
- Pharmacology
- Drug Interactions
- Clinical Pharmacy
Background:
- Antiretroviral agents and statins are independently known to cause drug-drug interactions.
- Combined use necessitates understanding potential pharmacokinetic and pharmacodynamic alterations.
Purpose of the Study:
- To review current literature on drug interactions between statins and antiretroviral agents.
- To inform clinicians on selecting appropriate drug combinations and managing risks.
Main Methods:
- Review of current scientific literature on statin-antiretroviral interactions.
- Overview of pharmacokinetic properties of both drug classes.
Main Results:
- Combined use can result in reduced lipid-lowering effects due to increased statin metabolism.
- An increased risk of rhabdomyolysis is observed due to reduced statin metabolism or impaired hepatic uptake.
- Interactions involve cytochrome P450, UDP-glucuronosyltransferase, and organic anion polypeptide B transporter pathways.
Conclusions:
- Clinically significant interactions between statins and antiretroviral agents are confirmed.
- These interactions pose risks of statin toxicity or diminished lipid-lowering efficacy.
- Guidance is provided to aid clinicians in optimal drug selection and management.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Pharmacokinetics: Drug–Drug Interactions
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Retrovirus Life Cycles
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...

